Results 221 to 230 of about 389,122 (252)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1974
An earlier editorial inThe Journal, "Aspirin Can Be Dangerous" (228:609, 1974), called attention to the risk of administering aspirin or aspirin-containing compounds to patients with a hemorrhagic diathesis, especially hemophilia, or to patients with a propensity for or a history of peptic ulcer.
openaire +2 more sources
An earlier editorial inThe Journal, "Aspirin Can Be Dangerous" (228:609, 1974), called attention to the risk of administering aspirin or aspirin-containing compounds to patients with a hemorrhagic diathesis, especially hemophilia, or to patients with a propensity for or a history of peptic ulcer.
openaire +2 more sources
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
American Heart Journal, 2004A lack of aspirin effect on platelets after a myocardial infarction (MI) is associated with poor health outcome. This lack of effect may be due to biological resistance to aspirin or due to nonadherence (the patient is not taking the aspirin, hence it has no effect).
Rikardo Krakover +9 more
openaire +3 more sources
2002
Inhibition of TXA2-dependent platelet fuction by aspirin may lead to prevention of thrombosis as well as to excess bleeding.
openaire +5 more sources
Inhibition of TXA2-dependent platelet fuction by aspirin may lead to prevention of thrombosis as well as to excess bleeding.
openaire +5 more sources
Herz Kardiovaskuläre Erkrankungen, 2008
Recent clinical studies have shown that the expected antiplatelet effect of aspirin is not always achieved. From the laboratory point of view, resistance to aspirin is the inability to achieve the expected inhibition of platelet cyclooxygenase-(COX-)1 with prevention of platelet thromboxane (TX) A2 formation.
Norbert Zimmermann +2 more
openaire +3 more sources
Recent clinical studies have shown that the expected antiplatelet effect of aspirin is not always achieved. From the laboratory point of view, resistance to aspirin is the inability to achieve the expected inhibition of platelet cyclooxygenase-(COX-)1 with prevention of platelet thromboxane (TX) A2 formation.
Norbert Zimmermann +2 more
openaire +3 more sources
Chest, 2000
Aspirin is not only one of the best-documented medicines in the world, but also one of the most frequently used drugs of all times. In addition to its role as an analgesic, aspirin is being increasingly used in the prophylaxis of ischemic heart disease and strokes. The prevalence of aspirin intolerance is around 5 to 6%.
Sundeep Salvi, K. Suresh Babu
openaire +3 more sources
Aspirin is not only one of the best-documented medicines in the world, but also one of the most frequently used drugs of all times. In addition to its role as an analgesic, aspirin is being increasingly used in the prophylaxis of ischemic heart disease and strokes. The prevalence of aspirin intolerance is around 5 to 6%.
Sundeep Salvi, K. Suresh Babu
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1980
To the Editor.— The authors of the Aspirin Myocardial Infarction Study (AMIS) (243:661, 1980) state that the regular administration of aspirin in a dosage of 1.0 g/day does not reduce three-year mortality in patients with a history of myocardial infarction (MI). There is no reason to doubt this.
openaire +3 more sources
To the Editor.— The authors of the Aspirin Myocardial Infarction Study (AMIS) (243:661, 1980) state that the regular administration of aspirin in a dosage of 1.0 g/day does not reduce three-year mortality in patients with a history of myocardial infarction (MI). There is no reason to doubt this.
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1970
To the Editor.— Real progress in improving the lot of the hemophiliac depends on a broad understanding of his disease and on the utilization of those clinical observations that have contributed to the establishment of sound therapy. Unfortunately, the editorial on "Hemophilia Prophylaxis" ( 212 :2256-2257, 1970) failed in both aspects.
openaire +3 more sources
To the Editor.— Real progress in improving the lot of the hemophiliac depends on a broad understanding of his disease and on the utilization of those clinical observations that have contributed to the establishment of sound therapy. Unfortunately, the editorial on "Hemophilia Prophylaxis" ( 212 :2256-2257, 1970) failed in both aspects.
openaire +3 more sources
Annals of Internal Medicine, 1969
Excerpt A recent paper on structural changes in human serum albumin (HSA) induced by acetylsalicylic acid (1) raises additional questions about the differences between aspirin and other salicylates...
openaire +3 more sources
Excerpt A recent paper on structural changes in human serum albumin (HSA) induced by acetylsalicylic acid (1) raises additional questions about the differences between aspirin and other salicylates...
openaire +3 more sources
Journal of the American Pharmaceutical Association (1961), 1977
M, Mayersohn +3 more
openaire +2 more sources
M, Mayersohn +3 more
openaire +2 more sources